Antimicrobials : new and old molecules in the fight against multi-resistant bacteria, Flavia Marinelli, Olga Genilloud, editors

Resource Information

The instance Antimicrobials : new and old molecules in the fight against multi-resistant bacteria, Flavia Marinelli, Olga Genilloud, editors represents a material embodiment of a distinct intellectual or artistic creation found in University of Missouri-St. Louis Libraries. This resource is a combination of several types including: Instance, Electronic.

Image

http://images.btol.com/ContentCafe/Jacket.aspx?UserID=ebsco-test&Password=ebsco-test&Return=T&Value=9783642399671&Type=L

Label

Antimicrobials : new and old molecules in the fight against multi-resistant bacteria, Flavia Marinelli, Olga Genilloud, editors

Title remainder

new and old molecules in the fight against multi-resistant bacteria

Statement of responsibility

Flavia Marinelli, Olga Genilloud, editors

Instantiates

• Antimicrobials : new and old molecules in the fight against multi-resistant bacteria

Publication

• Heidelberg, Springer, 2013?

Copyright

• ©2014

Antecedent source

unknown

Bibliography note

Includes bibliographical references and index

Carrier category

online resource

Carrier category code

• cr

Carrier MARC source

rdacarrier

Color

multicolored

Content category

text

Content type code

• txt

Content type MARC source

rdacontent

Contents

• Preface; Contents; Part ICurrent Trends in Antibiotics, Pathogens and Medical Needs; 1 The Origin and Evolution of Antibiotics; Abstract; 1.1 ... Introduction; 1.2 ... What's in a Name?; 1.3 ... Many Sources, Uses, and Functions; 1.4 ... How Old Are ''Antibiotics''?; 1.5 ... Antibiotic Myths; 1.6 ... Mode of Action and Evolution of Targets; 1.7 ... Parallel Chemical and Protein Evolution; 1.8 ... Conclusions; References; 2 Novel Infectious Diseases and Emerging Gram-Positive Multi-Resistant Pathogens in Hospital and Community Acquired Infections; Abstract; 2.1 ... Introduction
• 2.2 ... Methicillin-Resistant S. aureus as a Cause of HospitalHospital- and Community-Acquired InfectionsCommunity-Acquired Infections2.3 ... Infections Caused by Glycopeptide-Resistant EnterococciEnterococci; 2.4 ... Issues with Clostridium difficileClostridium difficile Infections; 2.5 ... Conclusions; 3 Gram-Negative Pathogens: Overview of Novel and Emerging Resistant Pathogens and Drugs; Abstract; 3.1 ... Introduction; 3.2 ... MDR, XDR and PDR Pathogens, and Resistance Mechanisms; 3.2.1 Resistance to beta -Lactam Antibiotics; 3.2.2 Resistance to Aminoglycosides; 3.2.3 Resistance to Tigecycline
• 3.2.4 Resistance to Fluoroquinolones3.2.5 Resistance to Colistin; 3.2.6 Resistance to Phosphonic Acid Derivatives; 3.3 ... Emerging Gram-Negative Resistant Pathogens; 3.3.1 Pseudomonas aeruginosa; 3.3.1.1 Antibiotic Resistance Mechanisms; 3.3.1.2 Risk Factors for Infections and Resistance Development; 3.3.2 Acinetobacter baumannii; 3.3.2.1 Antibiotic Resistance Mechanisms; 3.3.2.2 Risk Factors for Infections and Resistance Development; 3.3.3 Enterobacteriaceae and Klebsiella pneumoniae; 3.3.3.1 Antibiotic Resistance Mechanisms; 3.3.3.2 Risk Factors for Infections and Resistance Development
• 3.3.3.3 Klebsiella pneumoniae3.4 ... The Complexity of the Resistance Problem; 3.4.1 Novel Antimicrobials; 3.4.2 Novel beta -Lactam and beta -Lactamase Inhibitors; 3.4.2.1 Novel Cephalosporins; 3.4.2.2 Novel Carbapenems; 3.4.2.3 Novel Monobactams; 3.4.2.4 Novel beta -Lactamase Inhibitors; 3.4.3 Novel Non beta -Lactam Antibiotic Compounds; 3.4.3.1 Compounds Belonging to Known Class of Antimicrobial Agents; 3.4.3.2 Compounds Which Represent New Classes of Antimicrobials; 3.5 ... Conclusions; References; Part IIFamilies of Novel Candidates and Conventional Antibiotics
• 4 The beta -Lactam Antibiotics: Their Future in the Face of ResistanceAbstract; 4.1 ... Introduction; 4.2 ... Recent Advances in the Chemistry of the beta -Lactams; 4.2.1 New Cephalosporins; 4.2.1.1 Latest Generation Cephalosporins; 4.2.1.2 beta -Lactam Hybrid Structures; 4.2.1.3 TD-1792, A Covalent Cephalosporin-Vancomycin Hybrid; 4.2.1.4 beta -Lactamase-Catalyzed Antibiotic Release from Cephalosporins; 4.2.2 New Generation Carbapenems; 4.2.2.1 Anti-Gram-Positive Carbapenems; 4.2.2.2 Anti-Gram-Negative Carbapenems; 4.2.2.3 The Future of the Carbapenems; 4.2.3 New Generation Monocyclic beta -Lactams

Control code

861746231

Dimensions

unknown

Extent

1 online resource (viii, 364 pages)

File format

unknown

Form of item

online

Isbn

9783642399671

Level of compression

unknown

Media category

computer

Media MARC source

rdamedia

Media type code

• c

Other control number

10.1007/978-3-642-39968-8

Other physical details

illustrations (some color)

Quality assurance targets

not applicable

Record ID

.b131742358

Reformatting quality

unknown

Sound

unknown sound

Specific material designation

remote

System control number

(OCoLC)861746231